Medical
Devices
IHSI’s Medical Device Horizon Scanning System will introduce an unprecedented level of transparency and foresight into the medical technology landscape. By applying proven pharmaceutical intelligence methodologies to medical devices, IHSI ensures that governments and healthcare decision-makers have the data they need to proactively manage new and emerging medical technologies.
Scope of the Medical Device Database
The IHSI Medical Device Horizon Scanning System will:
- Track new and emerging medical devices across all key therapeutic areas.
- Capture regulatory milestones, from early-stage clinical development to full market approval.
- Assess potential health system impacts, including cost implications, procurement challenges, and necessary infrastructure changes.
Key Features
IHSI does not accept funding or engage in agreements with pharmaceutical companies.Member states also contribute through dedicated personnel and expertise in horizon scanning and HTA activities.
- All data is collected and owned by IHSI and its member states.
- Decision-making is solely in the hands of governmental representatives to ensure unbiased intelligence.
Future Roadmap
IHSI does not accept funding or engage in agreements with pharmaceutical companies.
- All data is collected and owned by IHSI and its member states.
- Decision-making is solely in the hands of governmental representatives to ensure unbiased intelligence.
- Member states also contribute through dedicated personnel and expertise in horizon scanning and HTA activities.